HUMANA INC News
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of PBM business. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
see moreHUMANA INC Market News
6d
Humana $1B Notes and OIG Probe: What It Means Now!
- This article examines Humana’s recent $1 billion subordinated note offering and the OIG findings on unsupported Medicare Advantage diagnosis payments, explaining immediate financial and regulatory implications for HUM stock and what investors should monitor next.
13d
Humana Plunges: $3.5B Star-Rating Shock Hits Stock
Humana shares plunged after the company disclosed a $3.5B Medicare Advantage Star Ratings headwind, conservative 2026 guidance, an exit from unprofitable counties and a CMS proposal that implied nearly flat MA payment rates — all amplifying pressure on HUM stock.
27d
Humana Faces $3.5B Headwind; HUM Rebounds Star Cut
Humana (HUM) recently weathered a steep selloff after a CMS rate surprise and conservative 2026 guidance tied to a $3.5 billion Medicare Advantage Star Ratings shortfall. The company has taken concrete steps—county exits and benefit trims—while investors reacted with a multi-day rebound. Key near-term catalysts include CMS final 2027 rates and execution on CenterWell-driven cost and quality improvements.
16 Feb at 04:51
Humana Slides on $3.5B Star-Ratings Hit
Humana reported conservative 2026 guidance after Q4 results, citing a $3.5 billion headwind from lower Medicare Advantage Star Ratings. Strong membership growth contrasts with margin pressure driven by lost bonus payments and a muted CMS reimbursement update, prompting operational cuts and a sharp drop in HUM shares.
09 Feb at 04:51
Humana Falls After Medicare Advantage Rate Cut Now
Humana shares dropped sharply this week following a modest Medicare Advantage rate proposal and renewed risk-adjustment scrutiny. The 0.9% proposed rate increase for 2027 and related policy pressures are creating tangible margin risk for Humana, which is heavily exposed to Medicare Advantage enrollment.